KROS - Keros Therapeutics, Inc.

QQQ $ 473.14 $ -2.10 (-0.44 %)

DIA $ 417.33 $ 2.44 (0.59 %)

SPY $ 562.48 $ 0.83 (0.15 %)

TLT $ 101.29 $ 0.92 (0.92 %)

GLD $ 238.61 $ -0.02 (-0.01 %)

Previous Close

$ 55.62

Open

$ 57.06

Bid

$ 55.52 x 200

Ask

-- x --

Day's Range

$ 55.20 - $ 57.35

52 Week Range

$ 27.02 - $ 73.00

Volume

280,255

Average Volume

Market Cap

2.09B

Beta (5Y Monthly)

$ 0.88

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K
4	11-06-2023	09-30-2023	10-Q
5	08-07-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-03-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	03-09-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-25-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q
17	08-13-2020	06-30-2020	10-Q
18	05-22-2020	03-31-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

B of A Securities Maintains Buy on Keros T...
09/12/2024 17:47:10

B of A Securities analyst Greg Harrison maintains Keros Therapeutics (NASDAQ:KROS) with a Buy and lowers the price target fr...

why-recursion-pharmaceuticals-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Recursion Pharmaceuticals Shares Are T...
09/03/2024 17:41:09

vaxcyte-shoals-technologies-polestar-automotive-applied-optoelectronics-and-other-big-stocks-moving-higher-on-tuesday

Vaxcyte, Shoals Technologies, Polestar Aut...
09/03/2024 14:47:56

Keros Therapeutics Has Closed Screening Fo...
09/03/2024 12:24:54

Keros Therapeutics, Inc. ("Keros" or the "Company") (NASDAQ:KROS), a clinical-stage biopharmaceutical company f...

Keros Therapeutics Q2 EPS $(1.25) Misses $...
08/07/2024 20:24:21

Keros Therapeutics (NASDAQ:KROS) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of ...

analyst-sees-keros-therapeutics-as-next-acceleron-set-for-major-biotech-growth

Analyst Sees Keros Therapeutics As Next Ac...
06/25/2024 18:43:19

Keros Therapeutics is advancing novel therapies for hematological and cardiopulmonary disorders via TGF-β signaling regulation....

Oppenheimer Initiates Coverage On Keros Th...
06/25/2024 09:45:35

Oppenheimer analyst Andreas Argyrides initiates coverage on Keros Therapeutics (NASDAQ:KROS) with a Outperform rating and an...

Truist Securities Maintains Buy on Keros T...
06/18/2024 17:48:55

Truist Securities analyst Srikripa Devarakonda maintains Keros Therapeutics (NASDAQ:KROS) with a Buy and maintains $100 pric...

HC Wainwright & Co. Reiterates Buy on Kero...
06/18/2024 10:25:18

HC Wainwright & Co. analyst Andrew Fein reiterates Keros Therapeutics (NASDAQ:KROS) with a Buy and maintains $100 price ...

Keros Therapeutics Appointed Jasbir S. See...
06/17/2024 20:08:05

Keros Therapeutics Presented Additional Da...
06/17/2024 10:05:02

Elritercept continued to demonstrate a durable transfusion independence in lower-risk myelodysplastic syndromes, including in...

HC Wainwright & Co. Reiterates Buy on Kero...
05/09/2024 11:56:38

HC Wainwright & Co. analyst Andrew Fein reiterates Keros Therapeutics (NASDAQ:KROS) with a Buy and maintains $100 price ...

Keros Therapeutics Q1 EPS $(1.21) Beats $(...
05/08/2024 12:29:56

Keros Therapeutics (NASDAQ:KROS) reported quarterly losses of $(1.21) per share which beat the analyst consensus estimate of $(...

Piper Sandler Maintains Overweight on Kero...
03/27/2024 16:48:15

Piper Sandler analyst Joseph Catanzaro maintains Keros Therapeutics (NASDAQ:KROS) with a Overweight and maintains $105 price...

Keros Therapeutics Announces FDA Fast Trac...
03/14/2024 12:03:17

Truist Securities Reiterates Buy on Keros ...
03/13/2024 17:23:37

Truist Securities analyst Srikripa Devarakonda reiterates Keros Therapeutics (NASDAQ:KROS) with a Buy and maintains $100 pri...

HC Wainwright & Co. Reiterates Buy on Kero...
03/01/2024 11:40:44

HC Wainwright & Co. analyst Andrew Fein reiterates Keros Therapeutics (NASDAQ:KROS) with a Buy and maintains $100 price ...

Keros Therapeutics Q4 EPS $(1.34) Beats $(...
02/28/2024 21:33:21

Keros Therapeutics (NASDAQ:KROS) reported quarterly losses of $(1.34) per share which beat the analyst consensus estimate of $(...

why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Mobileye Global Shares Are Trading Low...
01/04/2024 18:37:44

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

Lamb Weston Posts Upbeat Results, Joins Om...
01/04/2024 15:12:36

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdin...